文献速递临床试验与 GCP基础与转化研究

心脏手术中氧疗风险(ROCS)试验:一项随机临床试验的研究方案

The Risk of Oxygen during Cardiac Surgery (ROCS) trial: study protocol for a randomized clinical trial.
PubMed 文献 · Trials · 2017-06-26

ROCS试验将200例心脏手术患者随机分为生理性氧合组(维持动脉血氧饱和度95%至97%所需的最低吸入氧浓度)与高氧合组(吸入氧浓度=1.0),主要临床终点为血清肌酐从基线至术后第2天的变化,主要机制终点为血浆F2-异前列腺素和异呋喃的变化;次要终点包括超氧化物生成、临床谵妄、心肌损伤和住院时间,并设内皮功能亚组研究。

要点

  • ROCS试验随机分配200例心脏手术患者接受生理性氧合或高氧合。
  • 主要临床终点为血清肌酐从基线至术后第2天的变化。
  • 主要机制终点为血浆F2-异前列腺素和异呋喃浓度的变化。

核心结论

  • ROCS试验将检验心脏手术中术中生理性氧合较高氧合减少氧化损伤和器官损伤的假设。

研究设计与样本

  • ROCS试验为随机临床试验,计划随机分配200例心脏手术患者。
  • 生理性氧合定义为维持动脉血血红蛋白饱和度95%至97%所需的最低吸入氧浓度(FIO2)。
  • 高氧合定义为术中吸入氧浓度(FIO2)=1.0。

关键数值与推荐

  • 主要临床终点为血清肌酐从基线至术后第2天的变化。
  • 主要机制终点为血浆F2-异前列腺素和异呋喃浓度的变化。
  • 次要终点包括超氧化物生成、临床谵妄、心肌损伤和住院时间。
  • 内皮功能亚组研究采用血流介导的血管舒张、外周动脉张力测定和心外膜脂肪小动脉的金属丝张力肌图检查氧疗和氧化应激对内皮功能的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anesthesiologists administer excess supplemental oxygen (hyper-oxygenation) to patients during surgery to avoid hypoxia. Hyper-oxygenation, however, may increase the generation of reactive oxygen species and cause oxidative damage. In cardiac surgery, increased oxidative damage has been associated with postoperative kidney and brain injury. We hypothesize that maintenance of normoxia during cardiac surgery (physiologic oxygenation) decreases kidney injury and oxidative damage compared to hyper-oxygenation. METHODS/DESIGN: The Risk of Oxygen during Cardiac Surgery (ROCS) trial will randomly assign 200 cardiac surgery patients to receive physiologic oxygenation, defined as the lowest fraction of inspired oxygen (FIO2) necessary to maintain an arterial hemoglobin saturation of 95 to 97%, or hyper-oxygenation (FIO2 = 1.0) during surgery. The primary clinical endpoint is serum creatinine change from baseline to postoperative day 2, and the primary mechanism endpoint is change in plasma concentrations of F2-isoprostanes and isofurans. Secondary endpoints include superoxide production, clinical delirium, myocardial injury, and length of stay. An endothelial function substudy will examine the effects of oxygen treatment and oxidative stress on endothelial function, measured using flow mediated dilation, peripheral arterial tonometry, and wire tension myography of epicardial fat arterioles. DISCUSSION: The ROCS trial will test the hypothesis that intraoperative physiologic oxygenation decreases oxidative damage and organ injury compared to hyper-oxygenation in patients undergoing cardiac surgery. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02361944 . Registered on the 30th of January 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lopez MG, Pretorius M, Shotwell MS, et al. The Risk of Oxygen during Cardiac Surgery (ROCS) trial: study protocol for a randomized clinical trial. Trials. 2017. PMID: 28651648. doi:10.1186/s13063-017-2021-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。